Plasma Prolactin and Growth Hormone Levels in Manic Patients Treated with Pimozide
- 1 March 1982
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 140 (3), 274-279
- https://doi.org/10.1192/bjp.140.3.274
Abstract
Summary: During two weeks' treatment of 11 manic patients with pimozide there was close correspondence between the timecourse of improvement in clinical ratings and the rise in plasma prolactin between the second and fourteenth day. There were no significant differences in growth hormone levels during the manic episodes compared to recovery. These findings are discussed in relation to the role of dopamine in the release of prolactin and growth hormone, and in the pathogenesis of mania.This publication has 30 references indexed in Scilit:
- Double‐blind comparative clinical trial of pimozide and chlorpromazine in maniaActa Psychiatrica Scandinavica, 1981
- Tuberoinfundibular dopamine neurons and the regulation of prolactin secretionPsychoneuroendocrinology, 1981
- The prolactin secretory response to neuroleptic drugs: Mechanisms, applications and limitationsPsychoneuroendocrinology, 1980
- Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illnessPsychological Medicine, 1980
- Clinical Significance of Plasma Drug and Prolactin Levels During Acute Chlorpromazine Treatment: A Replication StudyThe British Journal of Psychiatry, 1979
- Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medicationPsychological Medicine, 1978
- Relationship between prolactin response and antipsychotic effect of thioridazine in psychiatric patientsEuropean Journal of Clinical Pharmacology, 1978
- PimozideDrugs, 1976
- Radioimmunoassay of the neuroleptic drug pimozideLife Sciences, 1975
- Adrenergic Blockade and the Corticosteroid and Growth Hormone Responses to MethylamphetamineNature, 1970